Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion
Ischemia-reperfusion injury (IRI), which is triggered by a transient reduction or cessation of blood flow followed by reperfusion, is a significant cause of acute kidney injury (AKI). IRI can lead to acute cell death, tissue injury, and even permanent organ dysfunction. In the clinic, IRI contribute...
Saved in:
Main Authors: | Lian-Cheng Deng (Author), Tahereh Alinejad (Author), Saverio Bellusci (Author), Jin-San Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: The Fibroblast Growth Factor Signaling Pathway in Metabolic Regulation, Development, Disease, and Repair After Injury
by: Zhouguang Wang, et al.
Published: (2020) -
Fibroblast Growth Factor 10 Attenuates Renal Damage by Regulating Endoplasmic Reticulum Stress After Ischemia-Reperfusion Injury
by: Xiaohua Tan, et al.
Published: (2020) -
Role of curcumin in ischemia and reperfusion injury
by: Minglei Bi, et al.
Published: (2023) -
Ablation of Peroxiredoxin V Exacerbates Ischemia/Reperfusion-Induced Kidney Injury in Mice
by: Jiyoung Park, et al.
Published: (2020) -
Protective effects of mefunidone on ischemia-reperfusion injury/Folic acid-induced acute kidney injury
by: Jiajia Li, et al.
Published: (2022)